Cautionary guidelines for the use of opioids in chronic pain

American Journal on Addictions

Volumn 18, Issue 1, 2009, Pages 1-4

  Streltzer, Jon ^a,d   Ziegler, Penelope ^b   Johnson, Brian ^c  

^a UNIVERSITY OF HAWAII   (United States)

^b William J Farley Center   (United States)

^c STATE UNIVERSITY OF NEW YORK   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OPIATE;

ANTINOCICEPTION; CHRONIC DISEASE; CHRONIC DRUG ADMINISTRATION; CHRONIC PAIN; CLINICAL DECISION MAKING; DRUG MISUSE; DRUG MONITORING; HEALTH CARE POLICY; HUMAN; LONG TERM CARE; MORBIDITY; MORTALITY; OPIATE ADDICTION; PHYSICIAN; PRACTICE GUIDELINE; PRESCRIPTION; SHORT SURVEY; URINALYSIS;

ANALGESICS, OPIOID; CHRONIC DISEASE; HUMANS; PAIN; PRACTICE GUIDELINES AS TOPIC; SUBSTANCE-RELATED DISORDERS;

EID: 60549111216     PISSN: 10550496     EISSN: 15210391     Source Type: Journal    
DOI: 10.1080/10550490802544508     Document Type: Short Survey

References (19)

1. American Academy of Pain Medicine. The use of opioids for the treatment of chronic pain. A consensus statement from the American Academy of Pain Medicine and the American Pain Society. Clin J Pain. 1997;13:6-8.
2. Savage SR. Opioid use in the management of chronic pain. Med Clin North Am. 1999;83:761-786.
3. Rawson RA, Maxwell J, Rutkowski B. OxyContin abuse: Who are the users? Am J Psychiatry. 2007;164:1634-1636.
4. Von Korff M, Deyo RA. Potent opioids for chronic musculoskeletal pain: Flying blind? Pain. 2004;109:207-209.
5. Martin BI, Deyo RA, Mirza SK, et al. Expenditures and health status among adults with back and neck problems JAMA. 2008;299:656-664.
6. Moore TJ, Cohen MR, Furberg CD. Serious adverse drug events reported to the food and drug administration, 1998-2005. Arch Intern Med. 2007;167:1752-1759.
7. Streltzer J, Johansen L. Prescription drug dependence and evolving beliefs about chronic pain management. Am J Psychiatry. 2006;163:594-598.
8. Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D. Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment. Eur J Pain. 2006;10:287-333.
9. Eriksen J, Sjøgren P, Bruera E, Ekholm O, Rasmussen NK. Critical issues on opioids in chronic non-cancer pain: an epidemiological study. Pain. 2006;125:172-179.
10. Chang G, Chen L, Mao J. Opioid tolerance and hyperalgesia. Med Clin North Am. 2007;91:199-211.
11. Vanderah TW, Suenaga NM, Ossipov MH, Malan TP Jr, Lai J, Porreca F. Tonic descending facilitation from the rostral ventromedial medulla mediates opioid-induced abnormal pain and antinociceptive tolerance. J Neurosci. 2001;21:279-286.
12. Xie JY, Herman DS, Stiller CO, et al. Cholecystokinin in the rostral ventromedial medulla mediates opioid-induced hyperalgesia and antinociceptive tolerance. J Neurosci. 2005;25:409-416.
13. King T, Gardell LR, Wang R, et al. Role of NK-1 transmission in opioid-induced hyperalgesia. Pain. 2005;116:276-288.
14. Watkins LR, Hutchinson MR, Ledeboer A, Wieseler-Frank J, Milligan ED, Maier SF. Glia as the "bad guys": Implications for improving clinical pain control and the clinical utility of opioids. Brain Behav Immun. 2007;21:131-146.
15. Doverty M, White JM, Somogyi AA, Bochner F, Ali R, Ling W. Hyperalgesic responses in methadone maintenance patients. Pain. 2001;90:91-96.
16. Ballantyne JC, Mao J. Opioid therapy for chronic pain. N Engl J Med. 2003;349:1943-1953.
17. Waddell G, McCulloch JA, Kummel E, et al. Nonorganic physical signs in low back pain. Spine. 1980;5:117-125.
18. Streltzer J, Eliashof BA, Kline AE, Goebert D. Chronic pain disorder following physical injury. Psychosomatics. 2000;41:227-234.
19. Katz N, Fanciullo GJ. Role of urine toxicology testing in the management of chronic opioid therapy. Clin J Pain. 2002;18(4 Suppl.):S76-82.